Replies to post #199680 on Biotech Values

[DewDiligence]

ALQA -26% on “strategic alternatives” PR:

https://globenewswire.com/news-release/2017/11/09/1178485/0/en/Alliqua-BioMedical-Inc-Engages-Cowen-to-Assist-in-Evaluating-Potential-Strategic-Alternatives.html

Normally, these kinds of PRs make the share price go up.